A. Pataki

Loss of vertebral bone and mechanical strength in estrogen-deficient rats is prevented by long-term administration of zoledronic acid

G. Evans, M. Glatt, A. Pataki, 2004, Osteoporosis International.

Long-Term Zoledronic Acid Treatment Increases Bone Structure and Mechanical Strength of Long Bones of Ovariectomized Adult Rats

G. Evans, M. Glatt, A. Pataki, 2003, Calcified Tissue International.

The relevance of drug-induced organ pigmentation in animals

A. Pataki, G. Rentsch, 1976, Archives of Toxicology.

Effects of short‐term treatment with the bisphosphonates zoledronate and pamidronate on rat bone: A comparative histomorphometric study on the cancellous bone formed before, during, and after treatment

W. Jee, A. Pataki, J. Green, 1997, The Anatomical record.

Characterization of the Cerebroprotective Efficacy of the Competitive NMDA Receptor Antagonist CGP40116 in a Rat Model of Focal Cerebral Ischemia: An in vivo Magnetic Resonance Imaging Study

G. Fagg, Á. Pataki, A. Pataki, 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Histochemical study of monoamine oxidase latency in the liver of the rat

A. Pataki, 1975, Histochemistry.

Enzyme histochemistry of rat folic acid nephropathy.

W. Meier-Ruge, A. Pataki, K. Wiederhold, 1977, Beitrage zur Pathologie.